Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease
- Substances:Golimumab
Greece- Participants:18–64 years · 65+ years
- Substances:Golimumab
- Sponsor:Janssen Cilag International
Rare diseases
Investigational molecules
Locations
Back to Greece252 clinical trials in Heraklion, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
GreeceRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
GreeceStudy of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
GreecePhase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis
GreeceLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
GreeceA Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
GreeceSafety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
GreecePhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
GreeceLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GreeceBI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases
GreeceA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
GreeceA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
GreeceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on systemic lupus erythematosus and cutaneous lupus, evaluating novel therapeutic approaches. Studies aim to assess treatment effectiveness and long-term safety profiles.
Multiple trials exploring innovative medications for chronic autoimmune conditions.
Comprehensive studies investigating treatments for inflammatory bowel diseases, including trials for both mild and severe cases. Research focuses on combination therapies and long-term management strategies.
Advanced therapeutic approaches for chronic digestive conditions.
Innovative trials targeting various forms of lung cancer and breast cancer, with a focus on advanced and metastatic disease states. Studies evaluate new combination therapies and treatment approaches.
Exploring breakthrough treatments in cancer care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.